BIO - International Biopharmaceutical Industry

Home
Current
Features
Editorial
Archives
Archived
Issues
Events
Sponsored
Report
Company
Profile
A-D

E-M

N-S

T-Z

Menu
Application
Notes
News
eBooks

Aldevron
Podcast
Generic selectors

Exact matches only

Search in title

Search in content

Post Type Selectors

Current Edition

news

Upstream Bio, a richly funded startup, reveals its lead drug and research plans

An inflammatory disease drug cast aside by Astellas Pharma has a new owner in Upstream Bio, an emerging biotechnology startup led by industry veteran Samantha Truex a...

6 June 2022 news BIO | Drug

Continue Reading →

news

Solid Bio joins slate of biotech layoffs, shedding 35% of its workforce

Dive Brief: Gene therapy developer Solid Biosciences is laying off 35% of its employees, announcing Wednesday a plan to extend its current funds for another two ye...

28 April 2022 news BIO | Biotech

Continue Reading →

news

BIO18: Pfizer (sort of) inches back to neuro; Building ties with FDA

BIO hits its goal Three days into the BIO International convention, the industry group touted breaking the G...

8 June 2018 news BIO | BIO18

Continue Reading →

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Current Edition

Upcoming Events

Advertisement

Upstream Bio, a richly funded startup, reveals its lead drug and research plans

Solid Bio joins slate of biotech layoffs, shedding 35% of its workforce

BIO18: Pfizer (sort of) inches back to neuro; Building ties with FDA

International Biopharmaceutical Industry